WebMar 6, 2024 · Feng Zeng is a Therapeutic Area, Multiple Sclerosis, Medical Health Outcomes Research Head at Biogen based in Cambridge, Massachusetts. Previously , Feng was a Global Director, Strategy Lead, Evidence & Value Development, Neurology at EMD Serono and also held positions at La Jolla Pharmaceutical, West Health, … WebTherapeutic Areas Learn about some of the therapy areas we work in and find resources to ... Biogen provides a wide range of resources to support the educational development of healthcare professionals. More about Medical Education. Events View upcoming Biogen meetings, congress presentations and on-demand events content. More about Events.
Sage Therapeutics Gets $1.53B From Biogen in a Collaboration Deal
WebBiogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such ... WebMay 31, 2024 · Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several ... shyam singha roy download movie
Biogen R&D Day to Provide Overview of Diversified Pipeline and ...
WebBiogen Therapeutic. Providing quality products to improve the health and quality of life. READ MORE. Slide 1. ... Biogen Healthcare is an emerging, rapidly growing pharmaceutical company with proven capabilities in the area of product innovation, manufacturing and marketing. WebDec 14, 2024 · Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need. In 2024, Biogen launched a bold 20-year, $250 million initiative to address the deeply interrelated issues of climate, health ... WebAs pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to address key unmet medical needs and make a meaningful daily impact for people affected by SMA. Biogen’s SMA development program encompasses 10 clinical studies, which have included more than 460 individuals across a broad spectrum of patient populations. shyam singha roy collections